retatrutide weight loss clinical trials results VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide—A Game Changer in Obesity

Semaglutide mimics the glucagon-like peptide-1 (GLP-1) hormone that your body naturally releases after you eat

Non-invasive imaging tools have not been available for oxidative phosphorylation in tumors

Br J Nutr 89:239248 Xiao Q, Boushey RP, Drucker DJ, Brubaker PL (1999) Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans

Together, they create a synergistic effect that supports sustained growth hormone optimization while maintaining natural pulsatility

Higher doses increase side effect intensity and cost without proportionally increasing weight loss for patients already responding well